{"ORPHApacket":[{"ORPHApacketID":"231426","date":"2019-12-06 00:49:43","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"231426","Name":[{"lang":"en","label":"Pharyngeal-cervical-brachial variant of Guillain-Barr\u00c3\u00a9 syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231426","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Regional variant of Guillain-Barr\u00c3\u00a9 syndrome"}],"ORPHA":"231416","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231416"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Pharyngeal-cervical-brachial variant of Guillain-Barr\u00c3\u00a9 syndrome is a rare, acquired peripheral neuropathy disease characterized by rapidly progressive oropharyngeal (facial palsy, dysarthria) and cervicobrachial weakness, associated with upper limb weakness and hypo\/areflexia, in the absence of ophthalmoplegia, ataxia, altered consciousness, and prominent lower limb weakness. The presence of monospecific IgG anti-GT1a antibodies is associated."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"All ages"}]}]}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Multigenic\/multifactorial"}]},{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"5","Synonym":[{"lang":"en","label":"PCB variant of GBS"},{"lang":"en","label":"PCB variant of Guillain-Barr\u00c3\u00a9 syndrome"},{"lang":"en","label":"Pharyngeal-cervical-brachial weakness"},{"lang":"en","label":"Pharyngo-cervico-brachial variant of GBS"},{"lang":"en","label":"Pharyngo-cervico-brachial variant of Guillain-Barr\u00c3\u00a9 syndrome"}]}]}]}